|
RNGTT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.416200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.140400E-02 |
| Normal-vs-Stage2 |
2.138200E-01 |
| Normal-vs-Stage3 |
1.204640E-03 |
| Normal-vs-Stage4 |
5.620700E-03 |
| Stage1-vs-Stage2 |
9.715800E-01 |
| Stage1-vs-Stage3 |
5.578500E-02 |
| Stage1-vs-Stage4 |
1.416370E-01 |
| Stage2-vs-Stage3 |
2.795400E-01 |
| Stage2-vs-Stage4 |
3.518000E-01 |
| Stage3-vs-Stage4 |
8.956000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.855100E-03 |
| Normal-vs-AfricanAmerican |
7.616300E-03 |
| Normal-vs-Asian |
5.007400E-01 |
| Caucasian-vs-AfricanAmerican |
4.050200E-01 |
| Caucasian-vs-Asian |
8.043600E-01 |
| AfricanAmerican-vs-Asian |
5.522400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.543300E-03 |
| Normal-vs-Female |
2.886400E-02 |
| Male-vs-Female |
4.582200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.294100E-02 |
| Normal-vs-Age(41-60Yrs) |
6.300100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.859100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.096400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.326000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.970400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.302200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.614640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.302100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.541810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.856800E-01 |
| Normal-vs-Grade 2 |
1.732960E-01 |
| Normal-vs-Grade 3 |
2.791100E-04 |
| Normal-vs-Grade 4 |
2.621800E-03 |
| Grade 1-vs-Grade 2 |
5.829800E-01 |
| Grade 1-vs-Grade 3 |
7.289800E-02 |
| Grade 1-vs-Grade 4 |
1.177640E-01 |
| Grade 2-vs-Grade 3 |
3.860600E-03 |
| Grade 2-vs-Grade 4 |
3.465600E-02 |
| Grade 3-vs-Grade 4 |
8.247800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.780220E-01 |
| Normal-vs-ccB subtype |
1.066470E-02 |
| ccA subtype-vs-ccB subtype |
1.424030E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.603900E-02 |
| Normal-vs-N1 |
4.053800E-01 |
| N0-vs-N1 |
8.113400E-01 |
|
|
